Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)

. 2019 Jul 16;79(10):1060–1078. doi: 10.1055/a-0919-4959

Consensus-based Recommendation 4.E12
The report on the findings for lymphadenectomy specimens resected for vaginal cancer must include the following information: The number of affected lymph nodes compared to the number of resected lymph nodes together with information on the biopsy location and side (pelvic, poss. inguinofemoral) The size of the largest lymph node metastasis in mm Information whether lymph node metastasis has spread beyond the capsule or not Information on the presence/absence of isolated tumor cells in the lymph node, in lymphatic vessels in perinodal adipose tissue, and/or in the lymph node capsule

Consensus-based Recommendation 4.E12

Expert consensus

Strength of consensus +++

The report on the findings for lymphadenectomy specimens resected for vaginal cancer must include the following information:

The number of affected lymph nodes compared to the number of resected lymph nodes together with information on the biopsy location and side (pelvic, poss. inguinofemoral)
The size of the largest lymph node metastasis in mm
Information whether lymph node metastasis has spread beyond the capsule or not
Information on the presence/absence of isolated tumor cells in the lymph node, in lymphatic vessels in perinodal adipose tissue, and/or in the lymph node capsule